Search Results - "Kibar, Müge Üzerk"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Mean platelet volume in familial Mediterranean fever related AA amyloidosis and comparison with common primary glomerular diseases by Yildirim, Tolga, Kütahya, Berranur, Iş, Fatma, Erdevir, Mehmet, Üzerk Kibar, Müge, Koç, Neriman Sila, Ayhan, Emine Arzu, Yilmaz, Rahmi, Erdem, Yunus

    Published in Turkish journal of medical sciences (21-10-2021)
    “…Compared to healthy controls, mean platelet volume (MPV) is frequently higher in patients with Familial Mediterranean fever (FMF) but lower in AA amyloidosis…”
    Get more information
    Journal Article
  2. 2
  3. 3
  4. 4

    Canakinumab treatment in renal transplant recipients with familial Mediterranean fever by Yildirim, Tolga, Yilmaz, Rahmi, Uzerk Kibar, Muge, Erdem, Yunus

    Published in Journal of nephrology (01-06-2018)
    “…Colchicine is the first-line treatment for familial Mediterranean fever (FMF), preventing both inflammatory attacks as well as the development of amyloidosis…”
    Get full text
    Journal Article
  5. 5

    Cytoplasmic WT1 in IgA nephropathy, an indicator of poor prognosis associated with mesangial/peri-mesangial C4d by Tasar, Gozde Elif, Uzerk Kibar, Muge, Dag, Osman, Erdem, Yunus, Ertoy Baydar, Dilek, Saglam, Arzu

    Published in International urology and nephrology (01-03-2023)
    “…Background We aimed to investigate the immuno-histochemical expression of C4d, ADAM10 and WT1 in kidney biopsies of immunoglobulin A nephropathy (IgAN)…”
    Get full text
    Journal Article
  6. 6

    Baseline renal functions predict the effect of canakinumab on regression of proteinuria in patients with familial Mediterranean fever by Yildirim, Tolga, Yilmaz, Rahmi, Saglam, Arzu, Uzerk-Kibar, Muge, Jabrayilov, Jabrayil, Erdem, Yunus

    Published in Nefrología (01-11-2021)
    “…Canakinumab, an IL-1 blocking drug, decreases the frequency and severity of the attacks and decreases the proteinuria level in colchicine resistant/intolerant…”
    Get full text
    Journal Article
  7. 7
  8. 8

    MO296MEAN PLATELET VOLUME IN FAMILIAL MEDITERRANEAN FEVER RELATED AMYLOIDOSIS AND COMPARISON WITH COMMON PRIMARY GLOMERULAR DISEASES by Yildirim, Tolga, Kutahya, Berranur, Is, Fatma, Erdevir, Mehmet, Uzerk Kibar, Muge, Koc, Neriman Sila, Saglam, Arzu, Yilmaz, Seref Rahmi, Erdem, Yunus

    Published in Nephrology, dialysis, transplantation (29-05-2021)
    “…Abstract Background and Aims Compared to healthy controls, mean platelet volume (MPV) is frequently higher in patients with Familial Mediterranean fever (FMF)…”
    Get full text
    Journal Article
  9. 9

    Dismal Prognosis of Acute Allergic Tubulointerstitial Nephritis in Patients with AA Amyloidosis by Yildirim, Tolga, Gok-Oguz, Ebru, Koc, Neriman Sila, Uzerk-Kibar, Muge, Uner, Meral, Saglam, Emine Arzu, Yilmaz, Seref Rahmi, Ayli, Deniz, Erdem, Yunus

    Published in Nephron (2015) (2022)
    “…Patients with AA amyloidosis may present with acute kidney injury that progresses to end-stage kidney disease in a short period of time. Acute allergic…”
    Get more information
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Baseline renal functions predict the effect of canakinumab on regression of proteinuria in patients with familial Mediterranean fever by Yildirim, Tolga, Yilmaz, Rahmi, Saglam, Arzu, Uzerk-Kibar, Muge, Jabrayilov, Jabrayil, Erdem, Yunus

    Published in Nefrología (01-11-2021)
    “…Canakinumab, an IL-1 blocking drug, decreases the frequency and severity of the attacks and decreases the proteinuria level in colchicine resistant/intolerant…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Baseline renal functions predict the effect of canakinumab on regression of proteinuria in patients with familial Mediterranean fever by Tolga Yildirim, Rahmi Yilmaz, Arzu Saglam, Muge Uzerk-Kibar, Jabrayil Jabrayilov, Yunus Erdem

    Published in Nefrología (01-11-2021)
    “…Introduction and objectives: Canakinumab, an IL-1 blocking drug, decreases the frequency and severity of the attacks and decreases the proteinuria level in…”
    Get full text
    Journal Article